ScoreComparison
Why is Day One Biopharmaceuticals, Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -21.62% over the last 5 years
2
The company has declared negative results in Jan 70 after 4 consecutive negative quarters
- NET SALES(Q) At USD 39.8 MM has Fallen at -57.56%
- PRE-TAX PROFIT(Q) At USD -19.73 MM has Fallen at -154.56%
- NET PROFIT(Q) At USD -19.73 MM has Fallen at -153.26%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 162.75%, its profits have fallen by -80.1%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Day One Biopharmaceuticals, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Day One Biopharmaceuticals, Inc.
159.54%
0.70
102.10%
S&P 500
16.12%
0.77
19.29%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-21.62%
EBIT Growth (5y)
-223.62%
EBIT to Interest (avg)
-128.24
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.99
Sales to Capital Employed (avg)
0.25
Tax Ratio
11.53%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.89
EV to EBIT
-10.60
EV to EBITDA
-10.83
EV to Capital Employed
-1755.02
EV to Sales
13.13
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-33.66%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
NET PROFIT(HY)
Higher at USD -50.05 MM
-24What is not working for the Company
NET SALES(Q)
At USD 39.8 MM has Fallen at -57.56%
PRE-TAX PROFIT(Q)
At USD -19.73 MM has Fallen at -154.56%
NET PROFIT(Q)
At USD -19.73 MM has Fallen at -153.26%
RAW MATERIAL COST(Y)
Grown by 9.83% (YoY
Here's what is not working for Day One Biopharmaceuticals, Inc.
Net Sales
At USD 39.8 MM has Fallen at -57.56%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Pre-Tax Profit
At USD -19.73 MM has Fallen at -154.56%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -19.73 MM has Fallen at -153.26%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Raw Material Cost
Grown by 9.83% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
